Amedeo Smart

Free Medical Literature Service



Bacterial Infections and Mycoses

  Free Subscription

Articles published in
    May 2024
  1. ZWEIJPFENNING SMH, Aarnoutse R, Boeree MJ, Magis-Escurra C, et al
    Safety and Efficacy of Clofazimine as an Alternative for Rifampicin in Mycobacterium avium Complex Pulmonary Disease Treatment: Outcomes of a Randomized Trial.
    Chest. 2024;165:1082-1092.
    >> Share

    March 2024
  2. WALKER MK, Kadri SS
    Generalizing the Use of a Procalcitonin-Guided Antibiotic Algorithm to a New Era of SARS-CoV-2 Infection.
    Chest. 2024;165:e85-e86.
    >> Share

  3. THIZY G, Flahault A, Scemla A, Roux O, et al
    Legionnaires Disease in Solid Organ Transplant Recipients: A Decade-Long Nationwide Study in France.
    Chest. 2024;165:507-520.
    >> Share

  4. YAN M, Fraser B, McArthur E, Mehrabi M, et al
    External Validation of the BACES Score in Canadian Patients With Nontuberculous Mycobacterial Pulmonary Disease.
    Chest. 2024;165:521-528.
    >> Share

  5. AZAR MM
    A Diagnostic Approach to Fungal Pneumonia: An Infectious Diseases Perspective.
    Chest. 2024;165:559-572.
    >> Share

    February 2024
  6. GODET C, Brun AL, Couturaud F, Laurent F, et al
    CT Imaging Assessment of Response to Treatment in Allergic Bronchopulmonary Aspergillosis in Adults With Bronchial Asthma.
    Chest. 2024 Feb 20:S0012-3692(24)00261-7. doi: 10.1016/j.chest.2024.
    >> Share

  7. DAMARAJU V, Adimulam GR
    The Conundrum of TB vs Sarcoidosis.
    Chest. 2024;165:e57-e58.
    >> Share

  8. SHARMA A, Sharma A, Soubani AO
    Epidemiology of COVID 19-Associated Mucormycosis in the United States.
    Chest. 2024;165:307-312.
    >> Share

  9. IM Y, Kim SY, Kim DH, Jhun BW, et al
    Outcomes of Intermittent Multidrug IV Therapy for Refractory Mycobacterium abscessus Pulmonary Disease.
    Chest. 2024;165:288-302.
    >> Share

    January 2024
  10. TAJIMA Y, Tashiro T, Furukawa T, Murata K, et al
    Pulmonary Nocardiosis With Endobronchial Involvement Caused by Nocardiaaraoensis.
    Chest. 2024;165:e1-e4.
    >> Share

    December 2023
  11. KU JH, Henkle E, Carlson KF, Marino M, et al
    Tolerability outcomes of ATS/IDSA guideline-recommended multi-drug antibiotic treatment for Mycobacterium avium complex pulmonary disease in U.S. Medicare beneficiaries with bronchiectasis.
    Chest. 2023 Dec 10:S0012-3692(23)05846-4. doi: 10.1016/j.chest.2023.
    >> Share

    November 2023
  12. LOEBINGER MR, Quint JK, van der Laan R, Obradovic M, et al
    Risk Factors for Nontuberculous Mycobacterial Pulmonary Disease: A Systematic Literature Review and Meta-Analysis.
    Chest. 2023;164:1115-1124.
    >> Share

  13. KIM JY, Park J, Choi Y, Kim TS, et al
    Microbiological Cure at Treatment Completion Is Associated With Longer Survival in Patients With Mycobacterium avium Complex Pulmonary Disease.
    Chest. 2023;164:1108-1114.
    >> Share

  14. COSTE A, Conrad A, Porcher R, Poiree S, et al
    Improving Diagnosis of Pulmonary Mucormycosis: Leads From a Contemporary National Study of 114 Cases.
    Chest. 2023;164:1097-1107.
    >> Share

    October 2023
  15. SIEGEL SAR, Griffith DE, Philley JV, Brown-Elliott BA, et al
    Open-Label Trial of Amikacin Liposome Inhalation Suspension in Mycobacterium abscessus Lung Disease.
    Chest. 2023;164:846-859.
    >> Share

    September 2023
  16. LU LY, Lee HM, Burke A, Li Bassi G, et al
    Prevalence, Risk factors, Clinical features, and Outcome of Influenza-Associated Pulmonary Aspergillosis (IAPA) in Critically Ill Patients: a systematic review and meta-analysis.
    Chest. 2023 Sep 22:S0012-3692(23)05541-1. doi: 10.1016/j.chest.2023.
    >> Share

  17. OSAWA T, Watanabe M, Morimoto K, Yoshiyama T, et al
    AHL score for predicting mortality risk in patients with pulmonary tuberculosis.
    Chest. 2023 Sep 17:S0012-3692(23)05434-X. doi: 10.1016/j.chest.2023.
    >> Share

  18. PARDESHI G, Mave V, Gaikwad S, Kadam D, et al
    Glycated Haemoglobin Trajectories and their Association with Treatment Outcomes among Pulmonary Tuberculosis Cases in India - A Prospective Cohort Study.
    Chest. 2023 Sep 4:S0012-3692(23)05377-1. doi: 10.1016/j.chest.2023.
    >> Share

  19. HESSELS LM, Speksnijder E, Paternotte N, van Huisstede A, et al
    Procalcitonin-Guided Antibiotic Prescription in Patients With COVID-19: A Multicenter Observational Cohort Study.
    Chest. 2023;164:596-605.
    >> Share

    August 2023
  20. VIDYASAGARAN AL, Readshaw A, Boeckmann M, Jarde A, et al
    Is tobacco use associated with risk of recurrence and mortality among people with tuberculosis? A systematic review and meta-analysis.
    Chest. 2023 Aug 29:S0012-3692(23)05372-2. doi: 10.1016/j.chest.2023.
    >> Share

    July 2023
  21. JUNG MK, Lee SY, Min EJ, Ko JM, et al
    CT Differences of Pulmonary Tuberculosis According to Presence of Pleural Effusion.
    Chest. 2023 Jul 7:S0012-3692(23)00953-4. doi: 10.1016/j.chest.2023.
    >> Share

  22. COOPER R, Williams M, Fennelly KP
    Abandon the Acid-Fast Bacilli Smear for Patients With TB on Effective Treatment.
    Chest. 2023;164:21-23.
    >> Share

  23. HENKLE E, Quittner AL, Dieckmann NF, Franklin H, et al
    Patient-Reported Symptom and Health-Related Quality-of-Life Validation and Responsiveness During the First 6 Months of Treatment for Mycobacterium avium Complex Pulmonary Disease.
    Chest. 2023;164:53-64.
    >> Share

  24. NAKAYAMA I, Izawa J, Gibo K, Murakami S, et al
    Contamination of Blood Cultures From Arterial Catheters and Peripheral Venipuncture in Critically Ill Patients: A Prospective Multicenter Diagnostic Study.
    Chest. 2023;164:90-100.
    >> Share

    April 2023
  25. FERIOLI M, Ferrari M, Galasso T, Natali F, et al
    A 60-Year-Old Man With a Migratory Lobar Consolidation After Invasive Ventilation.
    Chest. 2023;163:e163-e166.
    >> Share

  26. KIM JY, Lee HW, Yim JJ, Kwak N, et al
    Outcomes of Adjunctive Surgery in Patients With Nontuberculous Mycobacterial Pulmonary Disease: A Systematic Review and Meta-analysis.
    Chest. 2023;163:763-777.
    >> Share

    March 2023
  27. PEREA L, Faner R, Solarat B, Shoemark A, et al
    Low salivary secretory leukocyte protease inhibitor levels are related to airway Pseudomonas aeruginosa infection in Bronchiectasis.
    Chest. 2023 Mar 8:S0012-3692(23)00318-5. doi: 10.1016/j.chest.2023.
    >> Share

    February 2023
  28. GRAMEGNA A, Narayana JK, Amati F, Stainer A, et al
    Microbial inflammatory networks in bronchiectasis exacerbators with Pseudomonas aeruginosa.
    Chest. 2023 Feb 16:S0012-3692(23)00259-3. doi: 10.1016/j.chest.2023.
    >> Share

  29. YAN M, Brode SK, Marras TK
    The Other Nontuberculous Mycobacteria: Clinical Aspects of Lung Disease Caused by Less Common Slowly Growing Nontuberculous Mycobacteria Species.
    Chest. 2023;163:281-291.
    >> Share

    January 2023
  30. WONG C, Martinez-Garcia MA
    Randomized Clinical Trials of Inhaled Antibiotics in Bronchiectasis: Cause for Optimism?
    Chest. 2023;163:3-5.
    >> Share

    November 2022
  31. KEIR HR, Chalmers JD
    COUNTERPOINT: Is Chronic Bacterial Infection Clinically Relevant in COPD? No.
    Chest. 2022;162:972-976.
    >> Share

  32. MARTINEZ-GARCIA MA, Alvar Agusti
    POINT: Is Chronic Bacterial Infection Clinically Relevant in COPD? Yes.
    Chest. 2022;162:970-972.
    >> Share

  33. LEE S, Lee HW, Kim HJ, Kim DK, et al
    Deep Learning-Based Prediction Model Using Radiography in Nontuberculous Mycobacterial Pulmonary Disease.
    Chest. 2022;162:995-1005.
    >> Share

    October 2022
  34. PAN SW, Shu CC
    Time to Consider Treatment Initiation for Patients With Nontuberculous Mycobacterial Lung Disease.
    Chest. 2022;162:e203-e204.
    >> Share

  35. HENDERSON K, Bilancia R, Choo-Kang B, Maclay J, et al
    An Unusual Case of Postpartum Empyema.
    Chest. 2022;162:e157-e159.
    >> Share

    September 2022
  36. DESHMUKH S, Sane M, Gaikwad S, Sahasrabudhe T, et al
    Sex differences in tuberculosis clinical presentation, drug exposure, and treatment outcomes in India.
    Chest. 2022 Sep 26. pii: S0012-3692(22)03893-4. doi: 10.1016/j.chest.2022.
    >> Share

  37. KIM Y, Yoon JH, Ryu J, Yang B, et al
    Gastroesophageal reflux disease increases susceptibility to non-tuberculous mycobacterial pulmonary disease.
    Chest. 2022 Sep 7. pii: S0012-3692(22)03704-7. doi: 10.1016/j.chest.2022.08.2228
    >> Share

    August 2022
  38. BLANC PD, Balmes JR, Redlich C
    Occupational Exposures in Nontuberculous Mycobacterial Pulmonary Disease.
    Chest. 2022;162:e106-e107.
    >> Share

    July 2022
  39. GUAN WJ, Xu JF, Luo H, Xu XX, et al
    A Double-blind Randomized Placebo-controlled Phase-3 Trial of Tobramycin Inhalation Solution in Adults with Bronchiectasis with Pseudomonas aeruginosa Infection.
    Chest. 2022 Jul 18. pii: S0012-3692(22)01247-8. doi: 10.1016/j.chest.2022.
    >> Share

  40. BARKER H, Chen C
    Pandemic Outbreaks and the Language of Violence: Discussing the Origins of the Black Death and COVID-19.
    Chest. 2022;162:196-201.
    >> Share

  41. GREEN HD, Jones AM
    Managing Pulmonary Infection in Adults With Cystic Fibrosis: Adult Cystic Fibrosis Series.
    Chest. 2022;162:66-75.
    >> Share

  42. HENRIETTE ZWEIJPFENNING SM, Chiron R, Essink S, Schildkraut J, et al
    Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET study.
    Chest. 2022;162:76-81.
    >> Share

    May 2022
  43. CHOTIRMALL SH, Aliberti S
    Leveraging the Omics Revolution for Nontuberculous Mycobacteria Biomarkers.
    Chest. 2022;161:1129-1131.
    >> Share

  44. IM Y, Hwang NY, Kim K, Kim H, et al
    Impact of Time Between Diagnosis and Treatment for Nontuberculous Mycobacterial Pulmonary Disease on Culture Conversion and All-Cause Mortality.
    Chest. 2022;161:1192-1200.
    >> Share

  45. PARK JW, Curtis JR, Jun KI, Kim TM, et al
    Primary Prophylaxis for Pneumocystis jirovecii Pneumonia in Patients Receiving Rituximab.
    Chest. 2022;161:1201-1210.
    >> Share

    April 2022
  46. MA X, Yu D, Jie B, Li LL, et al
    Endovascular Treatment of Central Pulmonary Arterial Pseudoaneurysms in the Context of Silicosis Combined with Pulmonary Tuberculosis.
    Chest. 2022 Apr 28. pii: S0012-3692(22)00880-7. doi: 10.1016/j.chest.2022.
    >> Share

  47. JUNG HI, Kim SA, Kim HJ, Yim JJ, et al
    Anxiety and Depression in Patients With Nontuberculous Mycobacterial Pulmonary Disease: A Prospective Cohort Study in South Korea.
    Chest. 2022;161:918-926.
    >> Share

    March 2022
  48. KUMAR K, Loebinger MR
    Nontuberculous Mycobacterial Pulmonary Disease: Clinical Epidemiologic Features, Risk Factors, and Diagnosis: The Nontuberculous Mycobacterial Series.
    Chest. 2022;161:637-646.
    >> Share

    February 2022
  49. LAU A, Lin C, Barrie J, Winter C, et al
    Chest. 2022 Feb 2. pii: S0012-3692(22)00214-8. doi: 10.1016/j.chest.2022.
    >> Share

  50. DANHO R, Schildkraut JA, Zweijpfenning SMH, Svensson EM, et al
    Mycobacterium Growth Indicator Tube Time-To-Positivity Can Serve As an Early Biomarker of Treatment Response in Mycobacterium avium Complex Pulmonary Disease.
    Chest. 2022;161:370-372.
    >> Share

  51. KU JH, Siegel SAR, Philley J, Schipper P, et al
    Outcomes of Resectional Thoracic Surgery for the Treatment of Pulmonary Nontuberculous Mycobacterial Disease in 105 Patients in the United States.
    Chest. 2022;161:365-369.
    >> Share

    January 2022
  52. MELCHERS M, Festen B, den Dekker BM, Mooren ERM, et al
    A 67-Year-Old Male Patient With COVID-19 With Worsening Respiratory Function and Acute Kidney Failure.
    Chest. 2022;161:e5-e11.
    >> Share

  53. GRIFFITH DE, Daley CL
    Introducing the Nontuberculous Mycobacteria Series for CHEST.
    Chest. 2022;161:1-2.
    >> Share

    POINT: In the Era of Cystic Fibrosis Transmembrane Regulator Protein Modulator Therapy, Are the Treatment Goals for Adults Now Different From Those for Children With Cystic Fibrosis? Yes.
    Chest. 2022;161:18-20.
    >> Share

  55. GRIFFITH DE, Daley CL
    Treatment of Mycobacterium abscessus Pulmonary Disease.
    Chest. 2022;161:64-75.
    >> Share

    December 2021
  56. MASKIN LP, Garcia Hernandez MH, Stryjewski ME, Rodriguez PO, et al
    A 31-Year-Old Man With Seizures, Brain Lesion, and Lung Nodules.
    Chest. 2021;160:e639-e643.
    >> Share

  57. TASHIRO H, Takahashi K, Haraguchi T, Jinnouchi K, et al
    A 45-Year-Old Man With Acute Chest Pain, Fever, and Dyspnea After Tooth Extraction.
    Chest. 2021;160:e623-e628.
    >> Share

  58. JONES TPW, Dabbaj S, Mandal I, Cleverley J, et al
    The Blood Neutrophil Count After 1 Month of Treatment Predicts the Radiologic Severity of Lung Disease at Treatment End.
    Chest. 2021;160:2030-2041.
    >> Share

  59. PREVOTS DR, Marras TK, Wang P, Mange KC, et al
    Hospitalization Risk for Medicare Beneficiaries With Nontuberculous Mycobacterial Pulmonary Disease.
    Chest. 2021;160:2042-2050.
    >> Share

    November 2021
  60. HULL RC, Huang JT, Barton AK, Keir HR, et al
    Sputum Proteomics in non-Tuberculous Mycobacterial Lung Disease.
    Chest. 2021 Nov 24. pii: S0012-3692(21)04412-3. doi: 10.1016/j.chest.2021.
    >> Share

  61. CORREA LF, Fritscher CC, Fritscher RT, da Silva TKB, et al
    Exclusively Tracheobronchial Paracoccidioidomycosis: A Rare Presentation.
    Chest. 2021;160:e499-e501.
    >> Share

  62. ZUPETIC J, Penaloza HF, Bain W, Hulver M, et al
    Elastase Activity From Pseudomonas aeruginosa Respiratory Isolates and ICU Mortality.
    Chest. 2021;160:1624-1633.
    >> Share

    October 2021
  63. THOMAS-RUDDEL D, Schlattmann P, Pletz M, Kurzai O, et al
    Risk factors for invasive candida infection in critically ill patients - a systematic review and meta-analysis.
    Chest. 2021 Oct 18. pii: S0012-3692(21)04112-X. doi: 10.1016/j.chest.2021.
    >> Share

  64. HERBERTS MB, Johnson TF, Escalante P
    A 70-Year-Old Man With Cough and Recurrent Respiratory Infections.
    Chest. 2021;160:e347-e350.
    >> Share

  65. MARCIANO BE, Olivier KN, Folio LR, Zerbe CS, et al
    Pulmonary Manifestations of GATA2 Deficiency.
    Chest. 2021;160:1350-1359.
    >> Share

  66. MUMMADI SR, Stoller JK, Lopez R, Kailasam K, et al
    Epidemiology of Adult Pleural Disease in the United States.
    Chest. 2021;160:1534-1551.
    >> Share

    September 2021
  67. GRIFFITH DE, Thomson R, Flume PA, Aksamit TR, et al
    Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease: Sustainability and Durability of Culture Conversion and Safety of Long-term Exposure.
    Chest. 2021;160:831-842.
    >> Share

    August 2021
  68. SAHA BK, Chong W
    A 61-Year-Old Man With Influenza Pneumonia and New Onset Hemoptysis.
    Chest. 2021;160:e181-e184.
    >> Share

  69. YU Q, Zhang Q, Yu J, Song Y, et al
    A 66-Year-Old Woman With Progressive Dyspnea and Obstructive Pneumonia.
    Chest. 2021;160:e177-e180.
    >> Share

  70. KANG N, Jeon K, Kim H, Kwon OJ, et al
    Outcomes of Inhaled Amikacin-Containing Multidrug Regimens for Mycobacterium abscessus Pulmonary Disease.
    Chest. 2021;160:436-445.
    >> Share

    July 2021
  71. AKSAMIT TR, Marras TK
    Clofazimine Drug Susceptibility Testing for Nontuberculous Mycobacteria: A Call to Arms.
    Chest. 2021;160:e90.
    >> Share

    June 2021
  72. BARROS AJ, Enfield KB, Kadl A
    Intraarterial Catheter Use Is Associated With Increased Risk of Hospital Onset Bacteremia: A Retrospective Cohort Study.
    Chest. 2021;159:2321-2324.
    >> Share

  73. GHEYATH B, Akram A, Gong R, Tovar J, et al
    A 70-Year-Old Man With Conspicuous Thigh Pain and ST-Segment Elevations.
    Chest. 2021;159:e403-e407.
    >> Share

  74. HAWES AM, Chou C, Co I
    An 80-Year-Old Man With Persistent Enterococcus faecalis Bacteremia.
    Chest. 2021;159:e377-e380.
    >> Share

  75. WEINGART MF, Li Q, Choi S, Maleki-Fischbach M, et al
    Analysis of Non-TB Mycobacterial Lung Disease in Patients With Primary Sjogren's Syndrome at a Referral Center.
    Chest. 2021;159:2218-2221.
    >> Share

    May 2021
  76. MCCALLUM GB, Oguoma VM, Versteegh LA, Wilson CA, et al
    Comparison of First Nations and non-First Nations children's profiles with bronchiectasis over two five-year periods from the Northern Territory, Australia.
    Chest. 2021 May 5. pii: S0012-3692(21)00865-5. doi: 10.1016/j.chest.2021.
    >> Share

  77. NADA KM, Nishi S, Duarte A
    Pneumonia and Poorly Controlled Diabetes.
    Chest. 2021;159:e343-e347.
    >> Share

  78. ALLGAIER J, Lagu T, Haessler S, Imrey PB, et al
    Risk Factors, Management, and Outcomes of Legionella Pneumonia in a Large, Nationally Representative Sample.
    Chest. 2021;159:1782-1792.
    >> Share

    April 2021
  79. SEHGAL IS, Basumatary NM, Dhooria S, Prasad KT, et al
    A randomized trial of Mycobacterium w in severe presumed Gram-negative sepsis (MIST).
    Chest. 2021 Apr 11. pii: S0012-3692(21)00680-2. doi: 10.1016/j.chest.2021.
    >> Share

  80. GRIFFITH DE, Aksamit TR
    Managing Mycobacterium avium Complex Lung Disease With a Little Help From My Friend.
    Chest. 2021;159:1372-1381.
    >> Share

    March 2021
  81. RHEDIN S, Lundholm C, Osvald EC, Almqvist C, et al
    Pneumonia in infancy and risk for asthma - the role of familial confounding and pneumococcal vaccination.
    Chest. 2021 Mar 13. pii: S0012-3692(21)00480-3. doi: 10.1016/j.chest.2021.
    >> Share

    February 2021
  82. METERSKY ML, Choate R
    The Association of Long-term Macrolide Therapy and Nontuberculous Mycobacterial Culture Positivity in Patients with Bronchiectasis.
    Chest. 2021 Feb 19. pii: S0012-3692(21)00283-X. doi: 10.1016/j.chest.2021.
    >> Share

    December 2020
  83. YANG B, Ryu J, Kim T, Jo YS, et al
    Impact of Bronchiectasis on incident NTM pulmonary disease: A 10-Year national cohort study.
    Chest. 2020 Dec 26. pii: S0012-3692(20)35503-3. doi: 10.1016/j.chest.2020.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016